New blood cancer therapy approved in the U.S. – National
Johnson & Johnson JNJ.N said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer. The therapy, Talvey, …